Bank of America Corp DE decreased its holdings in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 34.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 20,513 shares of the company's stock after selling 10,847 shares during the quarter. Bank of America Corp DE owned 0.05% of Phibro Animal Health worth $431,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of the stock. New York State Teachers Retirement System raised its stake in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after acquiring an additional 775 shares during the period. Rhumbline Advisers grew its holdings in shares of Phibro Animal Health by 0.6% during the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company's stock valued at $1,608,000 after purchasing an additional 484 shares during the last quarter. Csenge Advisory Group bought a new stake in shares of Phibro Animal Health in the 4th quarter valued at about $434,000. Principal Financial Group Inc. lifted its position in Phibro Animal Health by 2.8% in the fourth quarter. Principal Financial Group Inc. now owns 98,783 shares of the company's stock valued at $2,074,000 after purchasing an additional 2,696 shares during the last quarter. Finally, Cardinal Capital Management increased its position in shares of Phibro Animal Health by 5.3% in the fourth quarter. Cardinal Capital Management now owns 68,442 shares of the company's stock valued at $1,437,000 after acquiring an additional 3,456 shares during the period. Hedge funds and other institutional investors own 99.34% of the company's stock.
Analysts Set New Price Targets
Several brokerages have commented on PAHC. Morgan Stanley upped their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a report on Thursday, May 8th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $20.00.
Read Our Latest Research Report on Phibro Animal Health
Phibro Animal Health Trading Up 0.5%
Phibro Animal Health stock traded up $0.12 during midday trading on Thursday, reaching $24.51. The stock had a trading volume of 174,465 shares, compared to its average volume of 204,247. Phibro Animal Health Co. has a 52-week low of $16.16 and a 52-week high of $26.55. The company has a fifty day moving average of $21.01 and a 200 day moving average of $21.90. The firm has a market cap of $993.49 million, a price-to-earnings ratio of 51.06, a price-to-earnings-growth ratio of 0.45 and a beta of 0.74. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.11. The business had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, analysts anticipate that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.96%. Phibro Animal Health's dividend payout ratio is currently 61.54%.
About Phibro Animal Health
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
See Also

Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.